In this week’s RA/HCC discussion, we are looking at a few of the HCC modification changes. As previously discussed, the HCC changes are extensive and the information provided below are just a few examples of these V28 changes.
Neoplasm Disease Group
![](https://uasisolutions.com/wp-content/uploads/2023/11/KD-HCC-neoplasm-1024x356.png)
Liver Disease Group
![](https://uasisolutions.com/wp-content/uploads/2023/11/KD-HCC-liver-1024x230.png)
Blood Disease Group
![](https://uasisolutions.com/wp-content/uploads/2023/11/KD-HCC-blood-1024x429.png)
Cognitive Disease Group
![](https://uasisolutions.com/wp-content/uploads/2023/11/KD-HCC-Cognitive-1024x157.png)
Substance Use Disorder Disease Group
![](https://uasisolutions.com/wp-content/uploads/2023/11/KD-HCC-substance-1024x304.png)
The next RA/HCC post will be a little more technical as we discuss the implementation of V28 and what providers and organizations should expect going into 2024.